Trials / Conditions / Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive

Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive

3 registered clinical trials studyying Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Re NCT07166419	Ohio State University Comprehensive Cancer Center	Phase 1
Recruiting	HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After NCT03326921	Fred Hutchinson Cancer Center	Phase 1
Terminated	Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies NCT02381548	National Cancer Institute (NCI)	Phase 1